Barriers Prevent People with MS from Committing to Treatment

Tags:: Betaseron, Betaplus, Bayer, Healthcare, Pharmaceuticals, Inc., Copaxone, Rebif, Multiple, Sclerosis, Ms, Survey

Add video views to your Facebook Timeline:

Share
Embed
Download

Nearly all people (97 percent) with multiple sclerosis (MS) who have started treatment say their commitment to managing their disease in every way possible is their prime motivation for staying on therapy, according to a new North American survey of people with MS, results of which were released today at the Consortium of Multiple Sclerosis Centers annual meeting in Denver. However, the survey also found that people with the disease can face significant barriers that make it difficult for them to start or stay fully committed to an effective treatment regimen. For more information on this story and others, visit www.newsinfusion.com